Canopy Growth CGC
NASDAQ CGC
$1.02 -0.01 (-1.44%)
At close: Aug 20, 2026 · 10:59 AM UTC

Canopy Growth (CGC) Income from Non-Controlling Interests (2019 - 2025)

Canopy Growth (CGC) posted Income from Non-Controlling Interests of $95.5 million for Q4 2025, up 965.96% sequentially from -$11.0 million in Q3 2023.

Canopy Growth (CGC) Income from Non-Controlling Interests (2019 - 2025) Analysis & Trends

Canopy Growth has reported Income from Non-Controlling Interests for 6 years, with the latest figure at $95.5 million in Q4 2025.

  • Quarterly Income from Non-Controlling Interests changed N/A year-over-year to $95.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $84.5 million (changed N/A YoY) and the FY2025 annual result came in at -$1.3 million, changed N/A from the prior year.
  • Income from Non-Controlling Interests climbed to $95.5 million in Q4 2025 per CGC's latest filing, from -$11.0 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $95.5 million in Q4 2025 and troughed at -$11.0 million in Q3 2023.
  • A 4-year average of $4.7 million and a median of -$3.7 million in 2022 frame the typical range for Income from Non-Controlling Interests.
  • The sharpest annual moves came in 2022 and 2023: Income from Non-Controlling Interests soared 198.06% in 2022, then slumped 1015.95% in 2023.
  • Over 4 years, Income from Non-Controlling Interests stood at -$5.2 million in 2021, then surged by 38.26% to -$3.2 million in 2022, then slumped by 242.67% to -$11.0 million in 2023, then soared by 965.96% to $95.5 million in 2025.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $95.5 million, -$11.0 million, and -$2.8 million for Q4 2025, Q3 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - -
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn -
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn 376,434.15
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn -
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn -
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Canopy Growth 434.93 Mn 187.92 Mn 16.08 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 95.51 Mn
Sep 30, 2023 -11.03 Mn
Jun 30, 2023 -2.78 Mn
Mar 31, 2023 -5.57 Mn
Dec 31, 2022 -3.22 Mn
Sep 30, 2022 -988,335.91
Jun 30, 2022 -4.16 Mn
Mar 31, 2022 6.89 Mn
Dec 31, 2021 -5.21 Mn
Sep 30, 2021 -4.19 Mn
Jun 30, 2021 -2.00 Mn
Mar 31, 2021 -7.03 Mn
Dec 31, 2020 57.63 Mn
Sep 30, 2020 -48.40 Mn
Jun 30, 2020 -7.69 Mn
Mar 31, 2020 -17.44 Mn
Dec 31, 2019 -13.85 Mn
Sep 30, 2019 -12.33 Mn
Jun 30, 2019 -6.12 Mn